b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">32042629</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>14</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Print">2223-4691</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>8</Volume>\n                    <Issue>Suppl 5</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Dec</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Translational andrology and urology</Title>\n                <ISOAbbreviation>Transl Androl Urol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Challenges of urine-based molecular assays for the detection of urothelial cancer.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>S493-S496</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.21037/tau.2019.08.27</ELocationID>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>de Jong</LastName>\n                    <ForeName>Joep J</ForeName>\n                    <Initials>JJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>van Kessel</LastName>\n                    <ForeName>Kim E M</ForeName>\n                    <Initials>KEM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Roobol</LastName>\n                    <ForeName>Monique J</ForeName>\n                    <Initials>MJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Boormans</LastName>\n                    <ForeName>Joost L</ForeName>\n                    <Initials>JL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016421">Editorial</PublicationType>\n                <PublicationType UI="D016420">Comment</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>China</Country>\n            <MedlineTA>Transl Androl Urol</MedlineTA>\n            <NlmUniqueID>101581119</NlmUniqueID>\n            <ISSNLinking>2223-4683</ISSNLinking>\n        </MedlineJournalInfo>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="CommentOn">\n                <RefSource>Mod Pathol. 2019 Oct;32(10):1544-1550</RefSource>\n                <PMID Version="1">31028363</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <CoiStatement>Conflicts of Interest: JJJ has performed consulting activities for Decipher Biosciences. JJJ and KEK received travel grants from MDxHealth to attend scientific meetings. MJR has no conflict of interest to report. JLB has performed consulting activities for MSD, Roche, BMS and Janssen Pharmaceuticals and has a research agreement with Decipher Biosciences.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>2</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>2</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>2</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">32042629</ArticleId>\n            <ArticleId IdType="doi">10.21037/tau.2019.08.27</ArticleId>\n            <ArticleId IdType="pii">tau-08-S5-S493</ArticleId>\n            <ArticleId IdType="pmc">PMC6989843</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>JAMA Intern Med. 2019 Jul 29;:</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31355874</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur Urol Oncol. 2018 Aug;1(3):223-230</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31102625</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Treat Rev. 2018 Sep;69:39-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29902678</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Elife. 2018 Mar 20;7:</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29557778</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mod Pathol. 2019 Oct;32(10):1544-1550</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31028363</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur Urol. 2018 Dec;74(6):796-804</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30241973</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2010 Jun 1;16(11):3011-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20404005</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'